METHOD FOR TREATING GLIOBLASTOMA MULTIFORME

Abstract

The present invention relates to a method for treating glioblastoma multiforme including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Boswella sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.

Claims

1. A method for treating glioblastoma multiforme, comprising: administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Boswella sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.

2. The method of claim 1, wherein the Chinese medicine composition is prepared by the following steps: providing the first mixture; mixing the first mixture with water to form a second mixture; heating the second mixture to obtain a crude extract; and filtering the crude extract to keep a liquid extract and obtain the Chinese medicine composition.

3. The method of claim 1, wherein the first mixture comprises 2-10 parts by weight of Boswella sacra, 2-10 parts by weight of Commiphora molmol, 2-4 parts by weight of Angelica sinensis, 2-4 parts by weight of Ligusticum striatum, 2-4 parts by weight of Rehmannia glutinosa, 2-4 parts by weight of Paeonia veitchii, 2-4 parts by weight of Prunus persica, and 1-3 parts by weight of Carthamus tinctorius.

4. The method of claim 3, wherein the part by weight of the first mixture is 2.5-5 gram per part.

5. The method of claim 1, wherein the first mixture further comprises at least one ingredient selected from the group consisting of Dipsacus asperoides, Davallia mariesii, Achyranthes bidentate, Scutellaria baicalensis, Coptis teeta, Phellodendron amurense, Poria cocos, Alisma plantago-aquatic, Polyporus umbellatus, Atractylodes lancea, Gastrodia elata, Tetradium ruticarpum, Ephedra sinica, Notopterygium incisium, Bupleurum falcatum, Citri Reticulatae Pericarpium, Anredera cordifolia, Panax ginseng, Aconitum carmichaeli, Pimenta officinalis, Morus alba, and Glycyrrhiza uralensis.

6. The method of claim 5, wherein the first mixture further comprises at least one ingredient selected from the group consisting of 8-30 parts by weight of Dipsacus asperoides, 8-30 parts by weight of Davallia mariesii, 8-30 parts by weight of Achyranthes bidentate, 6-30 parts by weight of Scutellaria baicalensis, 4-30 parts by weight of Coptis teeta, 4-30 parts by weight of Phellodendron amurense, 4-30 parts by weight of Poria cocos, 4-20 Alisma plantago-aquatic, 3-5 parts by weight of Polyporus umbellatus, 2-5 parts by weight of Atractylodes lancea, 5-20 parts by weight of Gastrodia elata, 5-15 parts by weight of Tetradium ruticarpum, 1-3 parts by weight of Ephedra sinica, 3-4 parts by weight of Notopterygium incisium, 4-6 parts by weight of Bupleurum falcatum, 3-5parts by weight of Citri Reticulatae Pericarpium, 2-4 parts by weight of Anredera cordifolia, 2-4 parts by weight of Panax ginseng, parts 4-6 by weight of Aconitum carmichaeli, 4-6 parts by weight of Pimenta officinalis, 3-12 parts by weight of Morus alba, and 2-4 parts by weight of Glycyrrhiza uralensis.

7. The method of claim 6, wherein the part by weight of the first mixture is 2.5-5 gram per part.

8. The method of claim 1, wherein the first mixture further comprises Atractylodes lancea, Glycyrrhiza uralensis, Scutellaria baicalensis, Coptis teeta, Phellodendron amurense, Poria cocos, Alisma plantago-aquatica, Gastrodia elata, and Ephedra sinica.

9. The method of claim 8, wherein the first mixture further comprises Panax ginseng, Aconitum carmichaeli, and Pimenta officinalis.

10. The method of claim 9, wherein the first mixture further comprises Morus alba.

11. The method of claim 3, wherein the first mixture further comprises 2-5 parts by weight of Atractylodes lancea, 2-4 parts by weight of Glycyrrhiza uralensis, 6-30 parts by weight of Scutellaria baicalensis, 4-30 parts by weight of Coptis teeta, 4-30 parts by weight of Phellodendron amurense, 4-30 parts by weight of Poria cocos, 4-20 parts by weight of Alisma plantago-aquatica, 5-20 parts by weight of Gastrodia elata, and 1-3 parts by weight of Ephedra sinica.

12. The method of claim 11, wherein the first mixture further comprises 2-4 parts by weight of Panax ginseng, 4-6 parts by weight of Aconitum carmichaeli, and 4-6 parts by weight of Pimenta officinalis.

13. The method of claim 12, the first mixture further comprises 3-12 parts by weight of Morus alba.

14. The method of claim 1, wherein the method is used to inhibit division, replication, proliferation, invasion or transmigration of glioblastoma multiforme.

15. The method of claim 1, wherein the Chinese medicine composition is administered via oral administration or injection.

16. The method of claim 1, wherein the Chinese composition further comprises pharmaceutically acceptable carrier, stabilizer, diluent, dispersant, suspending agents, thickening agent, excipient, or the combination thereof.

Description

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

[0022] The following embodiments are meant to explain the implementation of the present invention, they should be construed as descriptive merely, and should not restrict the remaining part of the present invention. The person having ordinary skills in the art can easily understand other advantages and effects of the present invention. The present invention may also be implemented or applied by other different embodiments, and various details in this specification may also be modified and changed according to different viewpoints and applications without departing from the spirit of the invention.

[0023] Unless specified otherwise, all technical and scientific terms described in the specification and claims of the present invention are defined as follows. In the present invention, the singular term and “the”, may refer to one or more objects, unless specified otherwise. In addition, the term “comprise” is an open-ended transition word which does not limit to the items listed. The foregoing paragraphs are only systematic references and should not be construed as limitations for the subject of the invention. Unless specified otherwise, the materials used in the present invention are commercially available and easy to obtain. Possible sources for obtaining the materials are listed below and it is exemplary only.

[0024] In the following preparation examples, the part by weight is 3.75 gram per part.

Preparation Example 1

[0025] Provide 3 parts by weight of Boswella sacra, 3 parts by weight of Commiphora molmol, 3 parts by weight of Angelica sinensis, 3 parts by weight of Ligusticum striatum, 3 parts by weight of Rehmannia glutinosa, 3 parts by weight of Paeonia veitchii, 3 parts by weight of Prunus persica, and 1.5 parts by weight of Carthamus tinctorius to form a first mixture-1; mix the first mixture-1 with 1500 parts by weight of water to form a second mixture-1; decoct the second mixture-1 for 1 hour to form a crude extract being about 400 parts by weight; filter the crude extract and collect the filtrate to obtain a Chinese medicine composition-1 of the present preparation example.

Preparation Example 2

[0026] The first mixture-1 of Preparation Example 1 was added with 3 parts by weight of Atractylodes lancea, 3 parts by weight of Glycyrrhiza uralensis, 8-20 parts by weight of Scutellaria baicalensis, 5 parts by weight of Coptis teeta, 5 parts by weight of Phellodendron amurense, 5 parts by weight of Poria cocos, 5 parts by weight of Alisma plantago-aquatica, 8-12 parts by weight of Gastrodia elata, and 2-2.5 parts by weight of Ephedra sinica to form a first mixture-2. Then, extract the first mixture-2 in a manner similar to Preparation Example 1 to obtain a Chinese medicine composition-2 of the present preparation example.

Preparation Example 3

[0027] The first mixture-2 of Preparation Example 2 was added with 3 parts by weight of Panax ginseng, 5 parts by weight of Aconitum carmichaeli, and 5 parts by weight of Pimenta officinalis to form a first mixture-3. Then, extract the first mixture-3 in a manner similar to Preparation Example 1 to obtain a Chinese medicine composition-3 of the present preparation example. The addition of Panax ginseng, Aconitum carmichaeli, and Pimenta officinalis can increase cerebral perfusion pressure, in favor of cerebral collateral circulation, thereby protecting normal cells, increasing the metabolism of brain tumor necrotic cells, and promoting the regeneration of normal brain cells.

Preparation Example 4

[0028] The first mixture-3 of Preparation Example 3 was added with 5-18 parts by weight of Coptis teeta and 5-10 parts by weight of Morus alba to form a first mixture-4. Then, extract the first mixture-4 in a manner similar to Preparation Example 1 to obtain a Chinese medicine composition-4 of the present preparation example.

[0029] The addition of Coptis teeta and Morus alba can eliminate edema and brain cell inflammation, promote brain cell toxicity of necrotic tumors, and dissolve the blockage of cerebrovascular and lymphatic vessels caused by metabolic wastes.

Example 1

[0030] The patient with cerebellar medulloblastoma (WHD IV) of Example 1 had been performed with surgery.

[0031] A treatment of the present invention applied to the patient of Example 1 was described below. A daily dose of the Chinese medicine composition-2 of Preparation Example 2 was administered to the patient every day, wherein the daily dose of the Chinese medicine composition-2 of Preparation Example 2 was divided into aliquots for ter in die administration. A follow-up report indicated that the patient still took the Chinese medicine composition-2 as of the reporting date, and the tumor was alleviated completely.

Example 2

[0032] A postoperative chemotherapy and radiotherapy was performed in the patient with cerebellar medulloblastoma (WHD IV) of Example 2. In details, the patient was performed with a surgery, a radiotherapy ended in three months thereafter, and the patient then took Temozolomide (TMZ).

[0033] A treatment of the present invention applied to the patient of Example 2 was described below. A daily dose of the Chinese medicine composition-3 of Preparation Example 3 was administered to the patient every day, wherein the daily dose of the Chinese medicine composition-3 of Preparation Example 3 was divided into aliquots for ter in die administration. A follow-up report indicated that the patient still took the Chinese medicine composition-3 as of the reporting date, and the tumor was alleviated completely.

Example 3

[0034] A postoperative chemotherapy and radiotherapy was performed in the patient with cerebellar medulloblastoma (WHD IV) of Example 3, and the patient was complicated with diabetes. In details, the patient was performed with a surgery and the radiotherapy ended in three months thereafter, and the patient then took Temozolomide (TMZ).

[0035] A treatment of the present invention applied to the patient of Example 3 was described below. A daily dose of the Chinese medicine composition-4 of Preparation Example 4 was administered to the patient every day, wherein the daily dose of the Chinese medicine composition-4 of Preparation Example 4 was divided into aliquots for ter in die administration. A follow-up report indicated that the patient still took the Chinese medicine composition-4 as of the reporting date, and the patient's blood sugar level was back to normal. In addition, the patient's tumor was alleviated completely, and the complication caused by the chemotherapy and radiotherapy were gone.

[0036] Although the present invention has been explained in relation to its preferred embodiment, it is to be understood that many other possible modifications and variations can be made without departing from the spirit and scope of the invention as hereinafter claimed.